Anthony Rotunno

Anthony Rotunno currently serves as the VP/GM Site Head at OmniaBio since October 2023. Prior experience includes working as a Pharmaceutical Consultant at ACBR Pharma LLC from January 2023 to October 2023, and as the Founder and Executive roles at Lykan Bioscience from September 2016 to January 2023. Additionally, Anthony held the position of Operations Director at Pharmachem Acquisition Company from February 2015 to October 2016, overseeing production and supply chain operations. Previous roles include President at Northstar Biologics LLC and VP of US Manufacturing Operations at Dendreon Inc., where responsibility included managing immunotherapy manufacturing facilities. Anthony has also been the VP of US Microbial Operations at Lonza and Vice President, General Manager at Cambrex Corp., emphasizing extensive experience in biologics contract manufacturing and pharmaceutical consulting.